Yiliang Zhu

Dr. Yiliang Zhu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in JMIR Formative Research
Verified
Journal Article
Open access
TCTracie Collins
Tracie Collins
MGMugur Geana
Mugur Geana
KOKathryn Overton
Kathryn Overton
MBMary Benton
Mary Benton
LLLiuqiang Lu
Liuqiang Lu
YZYiliang Zhu
Yiliang Zhu
Background: Walking therapy improves functional outcomes in patients with peripheral artery disease (PAD). Less is known about the additive benefit of a dietary intervention. Objective: Our objectives were to develop a smartphone app and, as a pilot, explore its potential efficacy as compared to motivational interviewing (MI) to increase walking distance and promote weight loss in overweight/obese adults with PAD. Methods: We conducted a 3-month, 2-arm randomized pilot study at the University of Kansas. Inclusion criteria were BMI >27 kg/m2 and symptomatic PAD, defined by an ankle-brachial index <0.9. Patients were randomized into 2 groups: MI, delivered through in-person and telephone counseling, and app, a mobile smartphone app. Both interventions encouraged walking for exercise and healthy dietary habits (increasing fruits and vegetables and whole grains while reducing fat and sugary drinks). We assessed medical history at baseline. At baseline and 3 months, participants completed an assessment of 6-minute walking distance, weight, quality of life, exercise behaviors, and dietary habits. The primary outcome was 3-month change in walking distance. Secondary outcomes were changes in weight, quality of life, exercise behaviors, and dietary habits. We used a Wilcoxon rank-sum test to analyze the primary and secondary outcomes at 3 months within the MI and app groups and to compare the changes between the groups with adjustment for baseline. Results: We randomized 29 participants with a mean age of 66.03 (SD 8.12) years; 25 participants completed the trial. At baseline, mean walking distance among completers was 260.40 (SD 94.32) meters and 326.15 (SD 69.28) meters for MI and app participants, respectively. At 3 months, the mean walking distance was 298.67 (SD 101.20) meters and 331.19 (SD 58.63) meters for MI and app participants, respectively (group difference P=.03, adjusting for baseline). Increase in walking distance at 3 months was 40.5 meters (95% CI 6.77 to 61.34; P=.02) in MI group. At baseline, mean body weight was 253.10 (SD 59.45) lbs and 225.13 (SD 58.93) lbs for MI and app participants, respectively. At 3 months, mean body weight was 242.14 (SD 58.54) lbs and 223.44 (SD 59.54) lbs for MI and app, respectively (group difference P=.006, adjusting for baseline). Pre-post study decrease in weight was 10.1 lbs (95% CI –17.9 to –3.0) and 2.3 lbs (95% CI –3.4 to –0.7) in MI and app group, respectively. Comparing baseline to 3 months, there were no statistically significant differences in quality of life, exercise behaviors, or dietary habits. Conclusions: Our study demonstrates that MI can promote walking and weight loss in overweight/obese adults with PAD. The smartphone app showed a small weight loss but no statistically significant increase in walking distance. As this was a pilot study, future large-scale studies are needed to replicate the efficacy of MI to promote weight loss in overweight or obese adults with PAD. Trial Registration: ClinicalTrials.gov NCT03694652; https://clinicaltrials.gov/ct2/show/NCT03694652

25 November 2021 in Kidney360
Verified
Journal Article
Closed access
PDF file
KCKelly Chong
Kelly Chong
ILIgor Litvinovich
Igor Litvinovich
SCShan Shan Chen
Shan Shan Chen
YZYiliang Zhu
Yiliang Zhu
CAChristos Argyropoulos
Christos Argyropoulos
YNYue-Harn Ng
Yue-Harn Ng
Key Points: Donor race should not be used in models to predict allograft and patient survival. Removing donor race from the Kidney Donor Risk Index may reduce kidney discard by reclassifying approximately 50% of high kidney donor profile index kidneys. Future prediction models should focus on using relevant biologic factors rather than social constructs when trying to predict outcomes.

30 November 2023 in Rural and Remote Health
Verified
Journal Article
Open access
YWYanan Wu
Yanan Wu
XWXuefeng Wei
Xuefeng Wei
LZLiying Zhou
Liying Zhou
FEFenfen E
Fenfen E
YZYiliang Zhu
Yiliang Zhu
XLXiuxia Li
Xiuxia Li
RRH: Rural and Remote Health. Published article number: 8275 - The effectiveness of continuing education programmes for health workers in rural and remote areas: a systematic review and meta-analysis

10 June 2023 in Family Practice
Verified
Journal Article
Closed access
PDF file
LZLiying Zhou
Liying Zhou
XWXuefeng Wei
Xuefeng Wei
YWYanan Wu
Yanan Wu
XDXinxin Deng
Xinxin Deng
MXMeng Xu
Meng Xu
XLXiuxia Li
Xiuxia Li
Background: Village doctors, as gatekeepers of the health system for rural residents in China, are often confronted with adversity in providing the basic public healthcare services. Objective: We sought to summarize the training contents, training method, training location, and training costs most preferred by village doctors in China and hope to provide evidence and support for the government to deliver better training in the future. Methods: Eight databases were searched to include studies that reported on the training needs of village doctors in China. We undertook a systematic review and a narrative synthesis of data. Results: A total of 38 cross-sectional studies including 35,545 participants were included. In China, village doctors have extensive training needs. “Clinical knowledge and skill” and “diagnosis and treatment of common disease” were the most preferred training content; “continuing medical education” was the most preferred delivery method; above county- and county-level hospitals were the most desirable training locations, and the training costs were expected to be low or even free. Conclusion: Village doctors in various regions of China have similar preferences for training. Thus, future training should focus more on the training needs and preferences of village doctors.

11 December 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Open access
PKPraveen Kumar
Praveen Kumar
FMFariha Moomtaheen
Fariha Moomtaheen
SMScott A. Malec
Scott A. Malec
JYJeremy J. Yang
Jeremy J. Yang
CBCristian G. Bologa
Cristian G. Bologa
CLChristophe Gerard Lambert
Christophe Gerard Lambert
Accurate detection and prevalence estimation of behavioral health conditions, such as opioid use disorder (OUD), are crucial for identifying at-risk individuals, determining treatment needs, monitoring prevention and intervention efforts, and recruiting treatment-naive participants for clinical trials. The availability of extensive health data, combined with advancements in machine learning (ML) frameworks, has enabled researchers to employ various ML techniques to predict or identify OUD within patient health data. Ideally, we could directly estimate the prevalence, or the proportion of a population with a condition over time. However, underdiagnosis and undercoding of conditions in patient health records make it challenging to determine the true prevalence of these conditions and to identify at-risk patients with less severe conditions who are more likely to be missed. Consequently, patients without diagnoses may comprise positive and negative examples for a given condition. Treating all undiagnosed (uncoded) patients as negative when applying ML methods can introduce bias into models, affecting their predictive power. To address this issue, we employed Positive Unlabeled Learning Selected Not At Random (PULSNAR), a Positive and Unlabeled (PU) learning technique, to estimate the probability of a given patient having OUD during a time window and the overall population prevalence of OUD. In a sample of 3,342,044 commercially insured US patients with at least one opioid prescription filled, PULSNAR estimated that 5.08% of patients have a cumulative prevalence of OUD over a 2–5 a observation period, compared to the 1.35% with a recorded OUD diagnosis, with 73.5% of cases not diagnosed/coded. The prevalence estimates provided by PULSNAR are consistent with those reported in other studies.

1 April 2018 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
XLXiuxia Li
Xiuxia Li
LWLili Wei
Lili Wei
WSWenru Shang
Wenru Shang
XXXin Xing
Xin Xing
MYMin Yin
Min Yin
KYKehu Yang
Kehu Yang